Lv31
260 积分 2025-05-29 加入
Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy
1个月前
已完结
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
1个月前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
2个月前
已完结
Humanization of Camelid Single-Domain Antibodies
2个月前
已完结
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
3个月前
已完结
In vivo CAR T cell engineering: design principles and open questions
4个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
4个月前
已完结
In vivo CAR T cell engineering: design principles and open questions
4个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
4个月前
已完结
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
7个月前
已完结
皖公网安备34019202002308
